Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial

Authors

Institutions

Publication Details

Journal
American Journal of Respiratory and Critical Care Medicine
Published
2025-10-28
DOI
https://doi.org/10.1164/rccm.202410-1894oc
Citations
4
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
4.66

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial

Njira Lucia Lugogo, J. Christian Virchow, Lucía De Prado Gómez, Mario Castro et al.
4 citations
American Journal of Respiratory and Critical Care Medicine
Asthma and respiratory diseases
4.66
article

Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial

Njira Lucia Lugogo, J. Christian Virchow, Lucía De Prado Gómez, Mario Castro, Alberto Papi, Juby A. Jacob‐Nara, Christopher Edward Brightling, Eleanor M. Dunican, Celeste Porsbjerg, Vibeke Backer, Mei Zhang, Paul J. Rowe, Arnaud Bourdin, Harry Sacks, Yamo Deniz, Xavier Soler
article en
4 citations

Abstract

No abstract available for this paper.
American Journal of Respiratory and Critical Care MedicineVol. 212(2)
University College Dublin (IE), University of Copenhagen (DK), Centre National de la Recherche Scientifique (FR), University of Kansas (US), Inserm (FR), Regeneron (United States) (US), University of Ferrara (IT), University of Michigan (US), Frederiksberg Hospital (DK), Bispebjerg Hospital (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK), Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR), Sanofi (Spain) (ES), Sanofi (United States) (US), Michigan Medicine (US), St. Vincent's University Hospital (IE), University of Kansas Medical Center (US), Universitätsmedizin Rostock (DE), Conseil Régional du Languedoc-Roussillon (FR), Sanofi (United Kingdom) (GB), NIHR Leicester Biomedical Research Centre (GB), University of Rostock (DE), IT University of Copenhagen (DK)
Sanofi, Regeneron Pharmaceuticals
Openalex Percentile: Top 5%
Asthma and respiratory diseases
4.66
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.